Hendrickson H S, van Dam-Mieras M C
J Lipid Res. 1976 Jul;17(4):399-405.
Using quantitative data previously reported for the penetration of local anesthetics into lecithin monolayers, the effects of surface and subphase concentrations of anesthetics on the inhibition of pancreatic phospholipase A2 action on didecanoyl phosphatidylcholine monolayers was investigated. Inhibition as a function of subphase concentration of anesthetic was in the order: dibucaine greater than tetracaine greater than butacaine greater than lidocaine = procaine. Inhibition as a function of surface concentration showed no obvious correlation; procaine inhibited at a very low surface concentration, followed by lidocaine at a somewhat higher concentration, and tetracaine, butacaine and dibucaine only at rather high concentrations. Ultraviolet difference spectroscopy indicated an interaction between lidocaine and enzyme in the subphase. Fluorescence studies showed that lidocaine is a competitive inhibitor of enzyme-lipid interface interaction. It is proposed that the more surface-active anesthetics inhibit by surface effects while the less surface-active anesthetics (lidocaine and procaine) inhibit by interaction with the enzyme in the subphase, which prevents enzyme penetration at the monolayer interface.
利用先前报道的局部麻醉药渗透卵磷脂单层的定量数据,研究了麻醉药的表面浓度和亚相浓度对胰磷脂酶A2作用于二癸酰磷脂酰胆碱单层的抑制作用。作为麻醉药亚相浓度函数的抑制作用顺序为:丁卡因>丁哌卡因>利多卡因=普鲁卡因。作为表面浓度函数的抑制作用未显示出明显的相关性;普鲁卡因在非常低的表面浓度下产生抑制作用,其次是利多卡因在稍高的浓度下产生抑制作用,而丁卡因、丁哌卡因和丁卡因仅在相当高的浓度下产生抑制作用。紫外差示光谱表明利多卡因与亚相中的酶之间存在相互作用。荧光研究表明利多卡因是酶-脂质界面相互作用的竞争性抑制剂。有人提出,表面活性较高的麻醉药通过表面效应产生抑制作用,而表面活性较低的麻醉药(利多卡因和普鲁卡因)通过与亚相中的酶相互作用产生抑制作用,这会阻止酶在单层界面处的渗透。